HBO’s “The Last of Us" captivated audiences with its gripping portrayal of a post-apocalyptic world ravaged by a fungal infection. While this scenario remains fictional, the threat of fungal infections to civilization is indeed a grim reality. This panel of infectious disease experts from industry, government, and academia, will explore real-life challenges posed by fungi, why fungal infections are becoming harder to treat, cross-resistance due to dual use of antifungals in both agriculture and medicine, and how our shared DNA with fungi makes it challenging to develop novel antifungals.
Programming descriptions are generated by participants and do not necessarily reflect the opinions of SXSW.
Tom Chiller, MD, MPHTM
Centers for Disease Control and Prevention (CDC)
Paul Verweij, MD, FECMM
Radboud University Medical Center of Expertise for Mycology